Nike Stock Named "Best Idea" at Guggenheim

Analysts have been optimistic toward NKE

by Emma Duncan

Published on Aug 23, 2019 at 10:20 AM

Athletic apparel giant Nike Inc (NYSE:NKE) is suffering a sharp pullback this morning, down 1% at $82.49, as Foot Locker (FL) headwinds offset a big bull note from Guggenheim. Specifically, the firm added NKE to its "Best Ideas" list, saying the company is positioned well to maneuver through tariff risks, and that Nike's latest earnings and robust product pipeline were impressive. Also of note, Nike has joined 31 other major retailers in signing a pact for better environmental efforts, which will be presented at this weekend's Group of Seven (G-7) summit.

Today's downside echoes the stock's recent technical troubles, with Nike shares down nearly 9% from its mid-July peak near $90. The security fell below $80 earlier this month, and a rebound off here was quickly contained by NKE's 160-day moving average.

Nevertheless, the majority of analysts share Guggenheim's optimism toward Nike stock. Prior to today, 13 of 19 covering firms maintained a "buy" or "strong buy" recommendation on the retail name. Plus, the security's average 12-month price target of $93.45 is a nearly 14% premium to current levels.

Meanwhile, the equity's Schaeffer's Volatility Index (SVI) of 24% ranks in the 21st annual percentile. This indicates the equity's front-month at-the-money options have priced in lower volatility expectations just 21% of the time over the last year, making options an attractive buy for traders at the moment.


START YOUR SATURDAY SMARTER.


The best of Schaeffer's market analysis in a 5-minute weekly read.


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.
Why Dermira, Menlo Therapeutics are Red-Hot Today
The broader stock market is much lower this afternoon, though
Banks, Blue Chips Kick Off Earnings Season
Dow earnings are expected to come in droves again next week
16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.